What Are Chemicals That Are Okay to Clean Your Home and Lab With?

Lab cleaning. Image by Tim Sandle 

Keeping your living areas and laboratory clean is necessary for health, safety, and effectiveness. Cleaning up regularly lowers the dangers of germs and helps to remove chemicals that can be harmful. Cleaned laboratories offer controlled conditions for experiments and ensure that data is kept accurate without contamination. A clean home improves your well-being by decreasing the risks of illnesses, allergies, and respiratory issues.

 

Below are several effective and secure chemicals are used for cleaning houses and laboratories.

 

Isopropyl Alcohol (IPA)

 

People use isopropyl alcohol because of its strong ability to clean and sterilize surfaces. With a typical strength of 70% or more, IPA is best known for killing germs and sanitizing various surfaces. You can safely use it to clean sensitive electronics, lab tools, and everyday household items such as keyboards and phones since it quickly evaporates with no residue.

 

Hydrogen Peroxide

 

Hydrogen peroxide can be used safely and is environmentally friendly when cleaning. Owing to its effective oxidizing action, it eliminates harmful microorganisms like bacteria, viruses, and fungi. No dangerous chemical remains after the reaction since it separates into water and oxygen, making it safe for daily and laboratory use. You can use hydrogen peroxide to clean your counters, sterilize equipment in a lab, and disinfect your bathrooms.

 

Acetic Acid (Vinegar)

 

Since vinegar is mainly made of acetic acid, it can be a safe and flexible cleaner. The high acidity in the detergent makes it efficient at dissolving mineral deposits and other unpleasant materials. Using vinegar is a safer way to clean than dangerous chemicals, but you should not combine vinegar with bleach because it will give off harmful chlorine gas.

 

Baking Soda (Sodium Bicarbonate)

 

Baking soda is appreciated for being abrasive and deodorizing, so it works well for various cleaning jobs. It is gentle for cleaning sensitive surfaces such as lab countertops, sinks, glassware, and household items that could be scratched. Baking soda is helpful at home to remove marks, reduce smells in carpets, and handle grease on surfaces in the kitchen.

 

Citric Acid

 

Adding citric acid makes it possible to remove calcium, rust, and soap leftovers. Maintaining equipment such as autoclaves and sterilizers that can collect minerals is often done in laboratories by using citric acid. It helps clean kitchens and washrooms, making devices like dishwashers safe from chemicals.

 

Even though there are safer ways to clean, it's important to realize that certain chemicals can be risky. Some home cleaning products and ingredients, such as bleach and ammonia, may irritate the skin, causing breathing and eye problems. A mixture of bleach with ammonia or acid (such as vinegar) causes toxic gases, namely chloramine and chlorine that can be harmful to breathe.

 

Cleaning chemicals should be used with good ventilation, proper protective equipment (gloves and masks), and well-labeled bottles in laboratories. Using alternatives such as isopropyl alcohol, hydrogen peroxide, vinegar, baking soda, and citric acid helps protect your health and leaves your surroundings safe and tidy. Rush University offers details on health benefit of cleaning, and the University of Colorado presents comprehensive cleaning and decontamination guidelines.

 

Written by Taylor McKnight, Author for Oxi Fresh Carpet Cleaning

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Key considerations for the selection of pharmaceutical equipment cleaning chemicals

Cleaning validation verifies the effectiveness of cleaning processes within pharmaceutical and healthcare facilities. It should be directed to situations or process steps where contamination or the carryover of materials pose the greatest risk to product quality (1), as evaluated to appropriate limits (2). To ensure cleaning process robustness, care must be taken in the selection of cleaning chemicals. This article looks at the choices available and some of the important selection factors for cleaning chemicals.

To determine the most appropriate chemicals, an understanding of the products is needed, especially with the selection of the most appropriate in-process material for the cleaning validation (3). This choice should be based on factors like solubility, difficulty of cleaning, the different types of equipment to be cleaned and the calculation of residue limits based on potency, toxicity, and stability.

Sandle, T.: Key considerations for the selection of pharmaceutical equipment cleaning chemicals, RSSL Insights, April 2023: https://www.rssl.com/insights/life-science-pharmaceuticals/key-considerations-for-the-selection-of-pharmaceutical-equipment-cleaning-chemicals/
 
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Exploring the Cost-Effective Advantages of Custom Synthesis in Drug Making

Image by Jynto Robert A. Rohde, Public Domain, https://commons.wikimedia.org/w/index.php?curid=24953730

The pharmaceutical industry is under constant pressure to innovate while managing costs. Developing new drugs is a complex and expensive process, often involving years of research, trials, and regulatory approvals. As companies strive to bring effective therapies to market more quickly and efficiently, custom synthesis has emerged as a valuable tool in reducing costs and enhancing the drug development process. This blog explores the cost-effective advantages of custom synthesis in drug making and how it supports the creation of high-quality active pharmaceutical ingredients (APIs).

Understanding Custom Synthesis in Drug Development

Custom synthesis refers to the tailored production of specific chemical compounds according to the unique requirements of a pharmaceutical company. These compounds may include intermediates, building blocks, or the API in drugs. The process is highly flexible, allowing companies to specify the exact properties, purity levels, and quantities needed for their drug development projects.

By outsourcing the synthesis of these compounds to specialized manufacturers, pharmaceutical companies can focus their internal resources on core activities such as research, development, and marketing. This approach not only reduces the burden on in-house teams but also ensures that the synthesized compounds meet the highest standards of quality and consistency.

Cost-Effective Benefits of Custom Synthesis

1.    Reduction in R&D Costs

 
○    One of the primary advantages of custom synthesis is the significant reduction in research and development (R&D) costs. Developing a new chemical compound from scratch requires substantial investment in equipment, raw materials, and skilled personnel. By partnering with a custom synthesis provider, pharmaceutical companies can leverage the provider’s expertise and infrastructure, eliminating the need for costly in-house development.

2.    Shortened Development Timelines

 
○    Speed is critical in the pharmaceutical industry, where getting a drug to market quickly can be the difference between success and failure. Custom synthesis allows companies to expedite the development process by outsourcing complex chemical synthesis tasks to experts. This can lead to shorter development timelines and faster time-to-market for new drugs, giving companies a competitive edge.

3.    Scalability and Flexibility

○    Custom synthesis offers unparalleled scalability and flexibility. Whether a company needs small quantities for early-stage research or larger batches for clinical trials, custom synthesis providers can adjust production volumes accordingly. This flexibility ensures that pharmaceutical companies can meet the varying demands of different stages of drug development without the need for significant capital investment.

4.    Access to Specialized Expertise

○    Custom synthesis providers often have specialized knowledge and experience in specific areas of chemistry, enabling them to tackle complex synthesis challenges that may be beyond the capabilities of a pharmaceutical company's in-house team. This access to expertise not only enhances the quality of the synthesized compounds but also helps in overcoming potential technical hurdles during drug development.

5.    Cost-Efficient Production of High-Quality APIs

○    The production of APIs is a critical aspect of drug development, and ensuring the quality of these ingredients is paramount. Custom synthesis enables the efficient and cost-effective production of high-quality APIs, meeting the stringent regulatory requirements of global markets. By using custom synthesis services, pharmaceutical companies can ensure that their APIs are produced to the exact specifications required for their drug formulations.

The Role of Custom Synthesis in API Development

APIs are the active components in drugs that produce the intended therapeutic effects. The quality and efficacy of a drug largely depend on the quality of its API. Custom synthesis plays a crucial role in API development by allowing pharmaceutical companies to obtain APIs that are tailored to their specific needs.

By utilizing custom synthesis services, companies can ensure that their APIs are produced with the required purity, potency, and stability. This is particularly important for complex or novel APIs that may require specialized synthesis techniques or processes. Custom synthesis also supports the production of APIs in compliance with Good Manufacturing Practices (GMP), ensuring that the final drug product is safe and effective for patient use.

Enhancing Innovation and Reducing Risk

Innovation is at the heart of the pharmaceutical industry, and custom synthesis contributes to this by enabling companies to explore new chemical entities and novel therapeutic approaches. By outsourcing synthesis tasks, companies can allocate more resources to innovative research, leading to the discovery of new drugs and treatments.

Moreover, custom synthesis reduces the risks associated with drug development. By working with experienced synthesis providers, companies can avoid potential pitfalls in the synthesis process, such as scalability issues or regulatory non-compliance. This reduces the likelihood of costly delays or failures during development and helps ensure a smoother path to market.

Conclusion

Custom synthesis offers significant cost-effective advantages in drug making, from reducing R&D costs to ensuring high-quality API production. By outsourcing to specialized providers, pharmaceutical companies can streamline development, focus on innovation, and bring new therapies to market more efficiently. Whether developing a new API or scaling up production, custom synthesis is a valuable tool that supports efficient and effective drug development.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

The Role of Specialty Chemistry in Drug Discovery and Development

Specialty chemistry is vital in drug discovery and development, offering advanced techniques to design, synthesize, and refine complex molecules. These processes are essential for creating effective drug candidates that address specific therapeutic targets.

By Swapna Kokate

 
What is Specialty Chemistry?

Specialty chemistry focuses on creating and manipulating complex molecules that standard chemistry can't easily produce. It includes precise synthesis, novel chemical reactions, and thorough molecular analysis, all critical for developing drugs with targeted biological effects.

Key Contributions to Drug Discovery and Development

1.    Complex Molecule Synthesis
○    Custom Design: Enables the creation of molecules with specific interactions, increasing the chances of developing effective drugs.
○    Lead Optimization: Refines drug candidates to improve properties like solubility, stability, and bioavailability, while minimizing side effects.
○    Chiral Synthesis: Involves producing enantiomerically pure compounds, which are often crucial for the safety and efficacy of drugs.

 

2.    Novel Chemical Reactions
○    Innovative Reactions: Develops unique chemical pathways to synthesize molecules that traditional methods cannot, opening new possibilities for drug discovery.
○    Catalysis and Reaction Efficiency: Focuses on optimizing reaction conditions to make processes more efficient and scalable, reducing time and costs in drug development.
○    Green Chemistry Approaches: Integrates environmentally friendly practices, reducing waste and using safer chemicals in drug synthesis.

3.    Advanced Analysis
○    Molecular Characterization: Employs sophisticated tools to determine molecular structure, purity, and stability, ensuring the quality of drug candidates.
○    Regulatory Compliance: Provides detailed documentation and validation of chemical processes, ensuring that drug candidates meet strict regulatory standards.
○    Structure-Activity Relationship (SAR) Studies: Uses chemical analysis to understand how molecular changes affect biological activity, guiding further drug optimization.

4.    Integration with Other Disciplines
○    Cross-Disciplinary Collaboration: Works closely with biology, pharmacology, and toxicology teams to ensure that chemical modifications lead to the desired biological outcomes.
○    Medicinal Chemistry Synergy: Collaborates with medicinal chemistry to enhance the design and synthesis of drug-like molecules, improving their drug development potential.
○    Material Science Applications: Applies specialty chemistry in creating drug delivery systems, such as nanoparticles or liposomes, that improve the effectiveness of therapeutics.
Aragen’s Specialty Chemistry Capabilities
●    Carbohydrates: Expertise in synthesizing complex oligosaccharides and glycoconjugates, essential for novel drug development.
●    Nucleosides/Nucleotides: Proficiency in creating complex nucleosides using ProTide technology, vital for antiviral and anticancer therapies.
●    Boron Chemistry: Skilled in synthesizing organoboron reagents and α-aminoboronic derivatives for key drug synthesis steps.
●    Protein Degraders: Development of PROTACs and related molecules for targeted protein degradation, crucial in cancer treatment.
●    Lipids: Advanced synthesis of complex lipids to enhance drug delivery systems.
●    Deuterium Chemistry: Expertise in creating deuterated compounds to improve drug stability and metabolism.

Specialty chemistry is foundational in drug discovery and development, enabling the synthesis and optimization of complex drug candidates. It drives innovation by creating unique molecules, optimizing lead compounds, and ensuring that drugs are both effective and safe. Aragen Life Sciences excels in specialty chemistry, providing the tools and expertise necessary to advance drug development from concept to market. Discover how our Specialty Chemistry and Small Molecules Discovery services can support your projects.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Covalent, Non-covalent, and Covalent Reversible Drug Design in Medicinal Chemistry

 Image: By Boghog2 - Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=7078192

Chemical drugs can be classified into three categories based on their binding modes: covalent drugs, non-covalent drugs, and covalent reversible drugs. Covalent drugs have strong binding ability and high efficacy, but they also come with strong toxic side effects. Non-covalent drugs have generally weaker binding ability, shorter duration of action, and relatively milder toxic side effects. Covalent reversible drugs, positioned between the other two categories, are considered relatively ideal, although their types are limited. Now, let’s discuss and summarize the chemical structures of these different types of drugs.

Covalent Drugs

Covalent drugs are primarily designed for amino acids with thiol or hydroxyl groups, such as cysteine, lysine, and serine. Well-known examples of covalent drugs include aspirin and penicillin (Fig. 1). The development of most covalent drugs involves intentionally introducing covalent bonding moieties that can interact with the target. Acrylamide is the most commonly used moiety, while epoxyethane and ethylene sulfonylamide are also common groups. The electrophilic groups on these drug molecules can undergo electrophilic-nucleophilic reactions with nucleophilic groups on the receptor, such as thiol, hydroxyl, amino, and imidazole groups, forming covalent bonds and achieving a higher level of receptor binding.

Fig. 1 Structure of Penicillin

A recently popular covalent drug is ibrutinib. Ibrutinib is an anti-tumor drug that inhibits the proliferation and survival of malignant B cells in vivo and the migration of cells in vitro, thereby inhibiting tumor growth.

Fig. 2 Structure of Ibrutinib

Non-covalent Drugs

Non-covalent drugs constitute the largest category of chemical drugs today, such as imatinib. Non-covalent drugs generally lack structures like unsaturated acrylamide and do not possess electrophilic properties. Traditional drug molecules, for the most part, are non-covalent drugs, and the forces of interaction between them and receptors are typically non-covalent, such as hydrogen bonding and dipole-dipole interactions.

Fig. 3 Structure of Imatinib

At the beginning of the new year, the FDA approved Loxo’s pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma (MCL) in adult patients. Pirtobrutinib is a third-generation BTK inhibitor and the first non-covalent BTK inhibitor.

Fig. 4 Structure of pirtobrutinib

Covalent Reversible Drugs

Common covalent reversible structures include carbonyl, cyanide, boronic acid, and so on (see Fig. 5).

Fig. 5 Common covalent reversible structures (Faridoon, Ng R, et al. 2023)

Alpha-cyanoacrylamide is a recently reported covalent reversible structure. This structure was first reported by Jack Taunton, who used a reversibly covalent inhibitor to target non-catalytic cysteine in Bruton’s tyrosine kinase, employing a reverse-oriented electrophilic reagent with cysteine-reactive cyanide acrylamide. The biochemical half-life of this structure ranges from minutes to 7 days. In vivo, the reverse cyanoacrylamide remains bound to proteins for over 18 hours after removal from circulation. This reverse cyanoacrylamide strategy has been further applied to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with several days of residence time, demonstrating the method’s generality.

Recently, Reja R M and others developed a new reversible lysine binder, characterized by new dinitrogen borane products and much slower dissociation kinetics compared to previously known subaminoboronic acid salts. Attaching the dinitrogen hetero-borane head RMR1 to a peptide ligand produces a potent and long-lasting reversible covalent inhibitor of staphylococcal sortase enzymes.

Conditionally reversible covalent inhibitors are also a new idea. The human body is a vast chemical reaction library, and various chemical reactions occur every day. A covalent inhibitor, under the influence of the body’s chemical reaction library, achieves a reversible effect. This design concept is a new way to design covalent compounds that degrade in the body’s chemical environment, similar to the design concept of prodrugs.

Rererences

Kim H , Hwang Y S , Kim M , et al. Recent advances in the development of covalent inhibitors[J]. RSC Medicinal Chemistry, 2021, 12(7):1037-1045.       

Faridoon, Ng R, Zhang G, et al. An update on the discovery and development of reversible covalent inhibitors[J]. Medicinal Chemistry Research, 2023: 1-24.       

J Michael Bradshaw , Jesse M McFarland , Ville O Paavilainen , Angelina Bisconte , Danny Tam , Vernon T Phan , Sergei Romanov , David Finkle , Jin Shu , Vaishali Patel , Tony Ton , Xiaoyan Li , David G Loughhead , Philip A Nunn , Dane E Karr , Mary E Gerritsen , Jens Oliver Funk , Timothy D Owens , Erik Verner , Ken A Brameld , Ronald J Hill , David M Goldstein , Jack Taunton. Prolonged and tunable residence time using reversible covalent kinase inhibitors，Nature Chemical Biology，2015，11：525-331.

Reja R M, Wang W, Lyu Y, et al. Lysine-targeting reversible covalent inhibitors with long residence time[J]. Journal of the American Chemical Society, 2022, 144(3): 1152-1157.

Author:

Carrier Taylor

R & D Director and Business Development Director of BOCSCI 

2014 - Present, working in BOCSCI

2012-2014 Study in Rice University, MBA

2004-2008 Study in Rice University,Pharmacy 

Linkedin profile: https://www.linkedin.com/in/carrier-taylor/ 

 

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)